| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aerovate Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12,500 | $204,625 | $16.37 | 05 Jun 2024 | Direct |
| Blueprint Medicines Corp | Director | Common Stock | 0 | $0 | $128.18 | 17 Jul 2025 | Direct |
| Relay Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 207,931 | 04 Nov 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 32,335 | 06 Nov 2025 | Direct | ||
| PepGen Inc. | Director | Stock Option (Right to Buy) | 16,000 | 04 Jun 2025 | Direct | ||
| Day One Biopharmaceuticals, Inc. | Director | Restricted Stock Unit (RSU) | 15,000 | 02 Jun 2025 | Direct | ||
| ACCELERON PHARMA INC | CEO and President, Director | Common Stock | 0 | $29.37 | 19 Nov 2021 | Direct | |
| ACCELERON PHARMA INC | CEO and President, Director | Option to Purchase Common Stock | 0 | 19 Nov 2021 | Direct | ||
| ALBIREO PHARMA, INC. | Director | Stock Options (Right to Buy) | 0 | 02 Mar 2023 | Direct | ||
| Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 0 | 17 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals, Inc. | 06 Nov 2025 | 4 | $0 | 4 | Director | 07 Nov 2025, 18:17 |
| RLAY | Relay Therapeutics, Inc. | 04 Nov 2025 | 1 | $0 | 4 | Director | 06 Nov 2025, 16:33 |
| RLAY | Relay Therapeutics, Inc. | 04 Nov 2025 | 0 | $0 | 3 | Director | 06 Nov 2025, 16:27 |
| BPMC | Blueprint Medicines Corp | 17 Jul 2025 | 5 | $0 | 4 | Director | 21 Jul 2025, 19:50 |
| BPMC | Blueprint Medicines Corp | 18 Jun 2025 | 1 | +$499,924 | 4 | Director | 24 Jun 2025, 16:22 |
| PEPG | PepGen Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 06:48 |
| DAWN | Day One Biopharmaceuticals, Inc. | 02 Jun 2025 | 2 | $0 | 4 | Director | 04 Jun 2025, 17:53 |
| PEPG | PepGen Inc. | 20 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 16:03 |
| BPMC | Blueprint Medicines Corp | 12 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 17:32 |
| AVTE | Aerovate Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 18:00 |
| DAWN | Day One Biopharmaceuticals, Inc. | 23 May 2024 | 1 | $0 | 4 | Director | 28 May 2024, 18:13 |
| AVTE | Aerovate Therapeutics, Inc. | 04 Mar 2024 | 1 | +$25,062 | 4 | Director | 06 Mar 2024, 18:00 |
| DAWN | Day One Biopharmaceuticals, Inc. | 17 Jan 2024 | 1 | $0 | 4 | Director | 19 Jan 2024, 17:19 |
| DAWN | Day One Biopharmaceuticals, Inc. | 17 Jan 2024 | 0 | $0 | 3 | Director | 19 Jan 2024, 17:01 |
| AVTE | Aerovate Therapeutics, Inc. | 02 Jan 2024 | 1 | +$39,984 | 4 | Director | 04 Jan 2024, 18:00 |
| AVTE | Aerovate Therapeutics, Inc. | 10 Jul 2023 | 1 | $0 | 4 | Director | 11 Jul 2023, 17:06 |
| AVTE | Aerovate Therapeutics, Inc. | 10 Jul 2023 | 0 | $0 | 3 | Director | 11 Jul 2023, 17:04 |
| PEPG | PepGen Inc. | 22 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 16:00 |
| BPMC | Blueprint Medicines Corp | 21 Jun 2023 | 2 | $0 | 4 | Director | 23 Jun 2023, 19:04 |
| ALBO | ALBIREO PHARMA, INC. | 02 Mar 2023 | 1 | $0 | 4 | Director | 02 Mar 2023, 15:41 |
| PEPG | PepGen Inc. | 03 Oct 2022 | 1 | $0 | 4 | Director | 03 Oct 2022, 17:14 |
| PEPG | PepGen Inc. | 20 Sep 2022 | 0 | $0 | 3 | Director | 22 Sep 2022, 16:15 |
| ALBO | ALBIREO PHARMA, INC. | 08 Aug 2022 | 1 | $0 | 4 | Director | 10 Aug 2022, 17:57 |
| ALBO | ALBIREO PHARMA, INC. | 08 Aug 2022 | 0 | $0 | 3 | Director | 10 Aug 2022, 17:55 |
| BPMC | Blueprint Medicines Corp | 23 Jun 2022 | 2 | $0 | 4 | Director | 27 Jun 2022, 18:45 |
| BPMC | Blueprint Medicines Corp | 23 Jun 2022 | 0 | $0 | 3 | Director | 27 Jun 2022, 18:36 |
| XLRN | ACCELERON PHARMA INC | 19 Nov 2021 | 6 | $0 | 4 | CEO and President, Director | 22 Nov 2021, 08:02 |
| XLRN | ACCELERON PHARMA INC | 01 Jul 2021 | 12 | -$9,178,942 | 4 | CEO and President, Director | 02 Jul 2021, 21:15 |